Please Wait...

IL-18 // Interleukin 18

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Interleukin 18 (IL-18) belongs to the IL-1 family and is produced by macrophages, dendritic cells and epithelial cells (keratinocytes). Pro-IL-18 is expressed constitutively and is then activated by caspase 1. Its receptor is IL-18R and the pro-inflammatory signaling requires the formation of a complex containing IL18, IL18R and IL-18RAP (Sims and Smith, 2010). In normal condition, IL-18 activity is lowered by high levels of IL-18 Binding Protein (IL-18BP). Binding of IL-18BP to IL-18 prevents its interaction with IL-18R. The ratio IL-18BP/IL-18 is altered in inflammatory conditions (Liang et al., 2006). Elevated levels of IL-18 have also been found to have a pertinent prognostic value in predicting cardiovascular mortality in patients with chronic kidney disease (Formanowicz et al., 2015).

Bioclinica Lab employs a manual sandwich immunoassay for the measurement of IL-18 in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a… https://t.co/VRIhWWf4tE
Bioclinica (5 days ago)
With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour… https://t.co/7ACrv8cvuF
Bioclinica (1 week ago)
Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff… https://t.co/vFhC7ITfZV
Bioclinica (2 weeks ago)
Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app… https://t.co/TJt2sZlrFP
Bioclinica (2 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/qIpi1MESXw
Bioclinica (3 weeks ago)
According to our recent poll, 45% of respondents had neither a #CTMS nor an #eTMF system, while only 24% had both.… https://t.co/l4dKC7pBQo
Bioclinica (3 weeks ago)